lemnalol has been researched along with Anasarca in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duh, CY; Huang, SY; Jean, YH; Lee, HP; Lin, SC; Lin, YY; Wang, HM; Wen, ZH; Wu, SF | 1 |
| Duh, CY; Huang, SY; Jean, YH; Lee, HP; Lin, YY; Wang, HM; Wen, ZH; Wu, SF | 1 |
2 other study(ies) available for lemnalol and Anasarca
| Article | Year |
|---|---|
Lemnalol attenuates mast cell activation and osteoclast activity in a gouty arthritis model.
Topics: Animals; Ankle; Ankle Joint; Anthozoa; Anti-Inflammatory Agents; Arthritis, Gouty; Biological Products; Disease Models, Animal; Edema; Male; Mast Cells; Osteoclasts; Rats, Wistar; Sesquiterpenes; Uric Acid | 2015 |
Soft coral-derived lemnalol alleviates monosodium urate-induced gouty arthritis in rats by inhibiting leukocyte infiltration and iNOS, COX-2 and c-Fos protein expression.
Topics: Animals; Anthozoa; Anti-Inflammatory Agents; Arthritis, Gouty; Colchicine; Cyclooxygenase 2; Edema; Inflammation; Leukocytes; Male; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Sesquiterpenes; Uric Acid | 2013 |